JP2022050596A5 - - Google Patents

Download PDF

Info

Publication number
JP2022050596A5
JP2022050596A5 JP2022003212A JP2022003212A JP2022050596A5 JP 2022050596 A5 JP2022050596 A5 JP 2022050596A5 JP 2022003212 A JP2022003212 A JP 2022003212A JP 2022003212 A JP2022003212 A JP 2022003212A JP 2022050596 A5 JP2022050596 A5 JP 2022050596A5
Authority
JP
Japan
Prior art keywords
cells
independently
carbon atoms
pharmaceutically acceptable
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022003212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022050596A (ja
Filing date
Publication date
Priority claimed from JP2020560042A external-priority patent/JP7016102B2/ja
Application filed filed Critical
Publication of JP2022050596A publication Critical patent/JP2022050596A/ja
Publication of JP2022050596A5 publication Critical patent/JP2022050596A5/ja
Pending legal-status Critical Current

Links

JP2022003212A 2018-12-06 2022-01-12 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤 Pending JP2022050596A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018229478 2018-12-06
JP2018229478 2018-12-06
JP2020560042A JP7016102B2 (ja) 2018-12-06 2019-12-06 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤
PCT/JP2019/047808 WO2020116606A1 (ja) 2018-12-06 2019-12-06 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020560042A Division JP7016102B2 (ja) 2018-12-06 2019-12-06 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤

Publications (2)

Publication Number Publication Date
JP2022050596A JP2022050596A (ja) 2022-03-30
JP2022050596A5 true JP2022050596A5 (https=) 2022-12-13

Family

ID=70974242

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020560042A Active JP7016102B2 (ja) 2018-12-06 2019-12-06 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤
JP2022003212A Pending JP2022050596A (ja) 2018-12-06 2022-01-12 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020560042A Active JP7016102B2 (ja) 2018-12-06 2019-12-06 Ｔ細胞又はｎｋ細胞の製造方法、ｔ細胞又はｎｋ細胞の培養用培地、ｔ細胞又はｎｋ細胞の培養方法、未分化ｔ細胞の未分化状態を維持する方法及びｔ細胞又はｎｋ細胞の増殖促進剤

Country Status (5)

Country Link
US (2) US12168781B2 (https=)
EP (1) EP3892722A4 (https=)
JP (2) JP7016102B2 (https=)
CN (1) CN113195710A (https=)
WO (1) WO2020116606A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12365871B2 (en) 2020-04-28 2025-07-22 Lyell Immunopharma, Inc. Methods for culturing cells
US20240309012A1 (en) * 2020-06-12 2024-09-19 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Isoquinoline compound, manufacturing method therefor, and application thereof
CN114031623B (zh) * 2021-11-12 2023-04-11 山西医科大学 一种c14位氨基取代粉防己碱衍生物及其制备和应用
EP4544027A1 (en) * 2022-06-27 2025-04-30 Kyoto University A method for producing ips cell -derived natural killer cells
CN115521914B (zh) * 2022-10-12 2024-04-19 西北工业大学 一种人原代自然杀伤细胞体外扩增体系及方法
WO2024113294A1 (zh) * 2022-12-01 2024-06-06 血霁生物科技(上海)有限公司 一种分化nk细胞的方法、培养基及其应用
CN117264886B (zh) * 2023-11-06 2024-03-19 深圳泽医细胞治疗集团有限公司 CD56dimCD16+NK细胞培养试剂盒、培养方法及应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734719A (en) 1968-11-13 1973-05-22 Airco Inc Oxy-fuel process for melting aluminum
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
WO2007023808A1 (ja) * 2005-08-23 2007-03-01 Fancl Corporation 皮膚老化マーカーとその利用技術
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
AU2008297011B2 (en) 2007-08-31 2014-06-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
US20100330063A1 (en) 2007-12-17 2010-12-30 Gliamed, Inc. Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
US20110014164A1 (en) 2008-02-15 2011-01-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
SG188904A1 (en) 2008-03-17 2013-04-30 Scripps Research Inst Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
AU2009234424A1 (en) 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator
CN101273989B (zh) * 2008-04-09 2011-02-09 浙江大学 一类小檗胺衍生物及其盐的应用
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
EP2313494A2 (en) 2008-07-14 2011-04-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/arid3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
WO2010050626A1 (en) 2008-10-30 2010-05-06 Kyoto University Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture
CN101429201A (zh) 2008-12-22 2009-05-13 浙江大学 柠檬酸小檗胺盐及制备方法和应用
JP5553289B2 (ja) 2009-02-27 2014-07-16 国立大学法人京都大学 新規核初期化物質
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111422A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US9062287B2 (en) 2009-09-11 2015-06-23 Takara Bio Inc. Process for production of natural killer cells
JPWO2011096482A1 (ja) 2010-02-03 2013-06-13 国立大学法人 東京大学 多能性幹細胞を用いた免疫機能再建法
US9206394B2 (en) 2010-02-03 2015-12-08 The University Of Tokyo Method for reconstructing immune function using pluripotent stem cells
DK2610257T3 (en) * 2010-08-27 2016-02-01 Hangzhou Bensheng Pharmaceutical Co Ltd DI-IMIDED DERIVATIVE OF BERBAMINE AND METHOD FOR PREPARING AND USING THEREOF
JP5695200B2 (ja) 2010-09-10 2015-04-01 ハンジョウ ベンシェン ファーマシューティカル シーオー．， エルティーディー．Ｈａｎｇｚｈｏｕ Ｂｅｎｓｈｅｎｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． 複素環アミノベルバミン誘導体、その調製方法及び使用
MX2014010185A (es) 2012-02-22 2014-11-14 Univ Pennsylvania Uso de dominio de señalizacion cd2 en receptores de antigeno quimericos de segunda generacion.
EP2902027A4 (en) * 2012-09-28 2016-06-22 Hangzhou Bensheng Pharmaceutical Co Ltd ACTIVE COMPOSITION FOR THE TREATMENT OF TUMORS AND THE USE THEREOF
EP3219791A4 (en) 2014-11-13 2018-07-18 Kyoto University Method for induction of t cells from pluripotent stem cells
US20160202242A1 (en) 2014-12-26 2016-07-14 Nitto Denko Corporation Cell death-inducing agent, cell growth-inhibiting agent, and pharmaceutical composition for treatment of disease caused by abnormal cell growth
US20160187319A1 (en) 2014-12-26 2016-06-30 Nitto Denko Corporation Cell death-inducing agent, cell growth-inhibiting agent, and pharmaceutical composition for treatment of disease caused by abnormal cell growth
WO2016122014A1 (ko) 2015-01-27 2016-08-04 한국생명공학연구원 자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도
US12398371B2 (en) 2015-01-27 2025-08-26 Korea Research Institute Of Bioscience Method for mass producing natural killer cell and use of natural killer cell obtained by the method as anti-cancer agent
IL260369B2 (en) 2016-01-06 2024-03-01 Lonza Ag Inhibition of protein breakdown for improved production
EP3476934A4 (en) 2016-06-23 2020-02-26 Kyoto University METHOD FOR PRODUCING CD4 / CD8 POSITIVE DUAL T CELLS

Similar Documents

Publication Publication Date Title
JP2022050596A5 (https=)
Jiang et al. T cell subsets in graft versus host disease and graft versus tumor
Wu et al. Granulocytic myeloid-derived suppressor cell exosomal prostaglandin E2 ameliorates collagen-induced arthritis by enhancing IL-10+ B cells
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
TWI645039B (zh) 無血清培養基及擴增造血幹細胞的方法
Meaker et al. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions
CN102356154A (zh) 从脐带血有效增殖和分化自然杀伤细胞的方法
JP4281071B1 (ja) Ｖγ９Ｖδ２Ｔ細胞の増殖剤、活性化Ｖγ９Ｖδ２Ｔ細胞の製造方法およびこれらの利用
US20230338429A1 (en) Compounds and use thereof in the expansion of stem cells and/or progenitor cells
US11673891B2 (en) Imidazopyrimidine compounds and uses thereof
CN107922926A (zh) 培养和/或使造血干细胞分化为祖细胞的方法及其用途
US12011460B2 (en) Expansion of NK and DC cells in vivo mediating immune response
Tijaro-Ovalle et al. Metabolic targets for improvement of allogeneic hematopoietic stem cell transplantation and graft-vs.-host disease
Sun et al. Clinical progress and preclinical insights into umbilical cord blood transplantation improvement
JP2023522727A (ja) 汎用型の臨床における異体ｄｎｔ細胞の複数回再注入用の効率的体外増幅方法
CN101313061A (zh) 扩增双阴性t细胞的方法
Ghaffari et al. Impact of various culture conditions on ex vivo expansion of polyclonal T cells for adoptive immunotherapy
Sakurai Recent advances in ex vivo expansion of human hematopoietic stem cells
CN118308300A (zh) 一种用于t细胞体外培养的细胞培养基及其制备方法和应用
CN106754705A (zh) 一种nk细胞培养基及体外扩增nk细胞的方法
WO2024117199A1 (ja) 組成物、細胞の生産方法、細胞、細胞の培養方法および組成物の生産方法
CN108486055B (zh) 培养基及其在中央记忆型t淋巴细胞培养中的应用
EP1389480A1 (en) Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
JP4482683B2 (ja) ｉｎｖｉｔｒｏで単球を成熟樹状細胞に分化させるためのＬ−α−リゾホスファチジルコリンの使用
Scott et al. Toward homeostasis: regulatory dendritic cells from the bone marrow of mice with inflammation of the airways and peritoneal cavity